Exelixis
EXEL • NASDAQ
Exelixis is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Morrissey, with a market cap of $10.8B.
Market Cap$10.8B
Employees1.3K
CEOMichael Morrissey
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Exelixis FAQ
Common questions about Exelixis
Exelixis is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $611.5M.
Exelixis has approximately 1,310 employees.